GIA
BIO icon

Gargoyle Investment Advisor’s Bio-Rad Laboratories Class A BIO Stock Holding History

Gargoyle Investment Advisor’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,537
Closed -$3.01M – 187
2016
Q4 		$3.01M Hold
16,537
– – 1.17% 17
2016
Q3 		$2.71M Sell
16,537
-2,600
-14% -$395K 1.03% 24
2016
Q2 		$2.74M Hold
19,137
– – 1.02% 20
2016
Q1 		$2.62M Buy
19,137
+2,600
+16% +$341K 0.88% 28
2015
Q4 		$2.29M Hold
16,537
– – 0.93% 39
2015
Q3 		$2.22M Hold
16,537
– – 0.91% 42
2015
Q2 		$2.49M Hold
16,537
– – 0.95% 38
2015
Q1 		$2.23M Buy
+16,537
New +$2.05M 0.84% 52

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Gargoyle Investment Advisor's BIO Position: Q1 2017 in Review

Gargoyle Investment Advisor sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2017, closing a stake of 16,537 shares — an estimated $3.01M sold.

Gargoyle Investment Advisor first reported a position in BIO in Q1 2015 and held it in 8 quarters. The position peaked at $3.01M in Q4 2016. 274 funds tracked by Wall St. Rank hold BIO as of Q1 2017.

  • Gargoyle Investment Advisor reported no remaining Bio-Rad Laboratories Class A position as of Q1 2017 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 16,537 Bio-Rad Laboratories Class A shares in Q1 2017, an estimated $3.01M.
  • Gargoyle Investment Advisor first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and held it in 8 quarters.
  • Gargoyle Investment Advisor's Bio-Rad Laboratories Class A position peaked at $3.01M in Q4 2016.
  • 274 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2017.

Based on Gargoyle Investment Advisor's 13F filing for Q1 2017, filed 3 May 2017.